Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases.
Skinuvita has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Skinuvita's investors include HTGF (High-Tech Gruenderfonds), GIMIC Ventures, Bremer Aufbau-Bank GmbH, Die Brückenköpfe, Meerkat Holding.
Skinuvita is headquartered in Bremen, Germany.
Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases.
Skinuvita is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Skinuvita — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/skinuvita. Accessed August 14, 2026.
VCBacked. (2024). Skinuvita — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/skinuvita
{{cite web |title=Skinuvita — Funding & Investors |url=https://www.vcbacked.co/company/skinuvita |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated